EMA recommends suspension of hydroxyprogesterone caproate medicines
The recommendation comes after studies raised possible safety concern and found 17-OHPC is not effective in preventing premature birth.
List view / Grid view
The recommendation comes after studies raised possible safety concern and found 17-OHPC is not effective in preventing premature birth.